AlphaFold predicted structure
GDF2 · Q9UK05

Mean pLDDT
74.6/ 100
Confident
429 residues
Confidence breakdown
- Very high(≥ 90)38%
- Confident(70–90)28%
- Low(50–70)12%
- Very low(< 50)21%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
growth differentiation factor 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Hereditary haemorrhagic telangiectasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedPulmonary arterial hypertension
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCerebral vascular malformations
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedhereditary hemorrhagic telangiectasia
heritable pulmonary arterial hypertension
hypertensive disorder
pulmonary arterial hypertension
Increased blood pressure
cardiovascular disorder
Abnormality of the cardiovascular system
hepatocellular carcinoma
Varicose veins
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Growth/differentiation factor 2
Potent circulating inhibitor of angiogenesis. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG
GDF2 · Q9UK05

Mean pLDDT
74.6/ 100
Confident
429 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0